InvestorsHub Logo
Followers 55
Posts 6414
Boards Moderated 1
Alias Born 07/28/2015

Re: None

Wednesday, 01/25/2023 11:05:35 PM

Wednesday, January 25, 2023 11:05:35 PM

Post# of 113612
There’s a huge problem with these three things

1) AEGIS demanded their shares be registered with the SEC and submitted the forms to do so AFTER the nasdaq uplist.

The SEC denies their request. AEGIS cannot dilute or sell their investment into SBFM because of this refusal by the SEC

2) Steve Slilaty demands the SEC expedite the security registration. SEC denies Slilaty as well.

3) Slilaty tries again and demands the unregistered shares be registered. SEC simply stated No, and stated further requests wouldn’t be reviewed.

End result, Slilaty nor AEGIS can not sell unregistered securities (shares) because they are simply, unregistered shares. This was in or about March when many institutional investors bailed.

This company is notorious for exaggerating the truth, not verifying claims or issuing a follow up. And lastly;

3) PPP loans that don’t qualify due to lack of American citizenship were given to 3 Canadian executives who claimed on all their reporting their place of residency is Canada. Not the USA.

This is a requirement, according to the SBA. Did any of these 3 spend at least 1/2 of each year in the USA at their registered residency?

One of the last issues is with SBFM-PL-4. This is cause for alarm because of their covid claims. The SEC went after and charged CytoDyn for near identical, unsubstantiated or unverifiable claims.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News